<code id='AEC6E5C908'></code><style id='AEC6E5C908'></style>
    • <acronym id='AEC6E5C908'></acronym>
      <center id='AEC6E5C908'><center id='AEC6E5C908'><tfoot id='AEC6E5C908'></tfoot></center><abbr id='AEC6E5C908'><dir id='AEC6E5C908'><tfoot id='AEC6E5C908'></tfoot><noframes id='AEC6E5C908'>

    • <optgroup id='AEC6E5C908'><strike id='AEC6E5C908'><sup id='AEC6E5C908'></sup></strike><code id='AEC6E5C908'></code></optgroup>
        1. <b id='AEC6E5C908'><label id='AEC6E5C908'><select id='AEC6E5C908'><dt id='AEC6E5C908'><span id='AEC6E5C908'></span></dt></select></label></b><u id='AEC6E5C908'></u>
          <i id='AEC6E5C908'><strike id='AEC6E5C908'><tt id='AEC6E5C908'><pre id='AEC6E5C908'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:38279
          Commuters wearing face masks walk along a pedestrian bridge during the evening rush hour in Beijing -- health coverage from STAT
          Mark Schiefelbein/AP

          Northeastern University has been selected for a leading role in a new national network formed to better forecast the spread of a future pandemic.

          The university announced Tuesday the US Centers for Disease Control and Prevention has awarded it $17.5 million over the next five years to develop a center focused on detecting and preparing for the next outbreak of infectious disease, especially in rural areas.

          advertisement

          Alessandro Vespignani, director of Northeastern’s Network Science Institute, is leading the project, called “EPISTORM: The Center for Advanced Epidemic Analytics and Predictive Modeling Technology.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Drug for rare kidney disease narrowly misses mark in clinical trial
          Drug for rare kidney disease narrowly misses mark in clinical trial

          AdobeTravereTherapeuticssaidThursdaythatastudymeanttoconfirmthebenefitofitsnewlyapproveddrugforarare

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Experts study whether long Covid risk adds up with each reinfection

          AstudyfromZiyadAl-Aly,clinicalepidemiologistatWashingtonUniversityinSt.Louis,showedthatvaccinationap